English
Zoom-Zoom+Black contrastBlue contrastWhite contrast

How to use the speech recognition tool?

NCT00643747

Safety Study of RPE65 Gene Therapy to Treat Leber Congenital Amaurosis

Safety Study of RPE65 Gene Therapy to Treat Leber Congenital Amaurosis

Type: Interventional



Status of the trial: Completed

Orphan Drug Recognition: NA

Inclusion

  • Opening Date: 2007-01-01
  • Closing Date: 2014-12-01

Criteria

More information

Children: No

Adults: No

Funder Type: industry

Principal location of the trial

HCP: Principal investigators

HCP: Other investigators


Within ERN-EYE members

Principal investigators




Other investigators

Workgroups

  • Retinal Rare Eye Diseases (WG1)

Subscribe to our mailing list

* indicates required

This ERN is supported by: